<?xml version='1.0' encoding='utf-8'?>
<document id="24392714"><sentence text="Interactions between valproic acid and quetiapine/olanzapine in the treatment of bipolar disorder and the role of therapeutic drug monitoring."><entity charOffset="21-34" id="DDI-PubMed.24392714.s1.e0" text="valproic acid" /><entity charOffset="39-49" id="DDI-PubMed.24392714.s1.e1" text="quetiapine" /><entity charOffset="50-60" id="DDI-PubMed.24392714.s1.e2" text="olanzapine" /><pair ddi="false" e1="DDI-PubMed.24392714.s1.e0" e2="DDI-PubMed.24392714.s1.e0" /><pair ddi="false" e1="DDI-PubMed.24392714.s1.e0" e2="DDI-PubMed.24392714.s1.e1" /><pair ddi="false" e1="DDI-PubMed.24392714.s1.e0" e2="DDI-PubMed.24392714.s1.e2" /><pair ddi="false" e1="DDI-PubMed.24392714.s1.e1" e2="DDI-PubMed.24392714.s1.e1" /><pair ddi="false" e1="DDI-PubMed.24392714.s1.e1" e2="DDI-PubMed.24392714.s1.e2" /></sentence><sentence text="The anticonvulsant valproic acid and the atypical antipsychotics olanzapine and quetiapine provide synergistic mood-stabilising, antidepressant and antipsychotic activities in the treatment of bipolar and schizoaffective disorders"><entity charOffset="19-32" id="DDI-PubMed.24392714.s2.e0" text="valproic acid" /><entity charOffset="65-75" id="DDI-PubMed.24392714.s2.e1" text="olanzapine" /><entity charOffset="80-90" id="DDI-PubMed.24392714.s2.e2" text="quetiapine" /><pair ddi="false" e1="DDI-PubMed.24392714.s2.e0" e2="DDI-PubMed.24392714.s2.e0" /><pair ddi="false" e1="DDI-PubMed.24392714.s2.e0" e2="DDI-PubMed.24392714.s2.e1" /><pair ddi="false" e1="DDI-PubMed.24392714.s2.e0" e2="DDI-PubMed.24392714.s2.e2" /><pair ddi="false" e1="DDI-PubMed.24392714.s2.e1" e2="DDI-PubMed.24392714.s2.e1" /><pair ddi="false" e1="DDI-PubMed.24392714.s2.e1" e2="DDI-PubMed.24392714.s2.e2" /></sentence><sentence text=" Existing literature shows that pharmacokinetic and pharmacodynamics drug-drug interactions (DDIs) possibly occur with the use of such a combination" /><sentence text=" Clinical reports of a possible interaction between the drugs leading to an increased risk of adverse drug reactions have also emerged" /><sentence text=" The main objective of this paper is to review the incidence of DDIs between the anticonvulsant and the antipsychotics, to postulate the possible mechanisms of the interaction and to establish whether certain target populations are at an increased susceptibility to such interactions" /><sentence text=" The usefulness of therapeutic drug monitoring (TDM) of the antipsychotics to monitor for an interaction was also assessed" /><sentence text=" A systematic database search was carried out using the search engine provided by PubMed using the following key words: olanzapine, quetiapine, valproic acid, pharmacokinetic drug-drug interaction, bipolar disorder, therapeutic drug monitoring"><entity charOffset="120-130" id="DDI-PubMed.24392714.s7.e0" text="olanzapine" /><entity charOffset="132-142" id="DDI-PubMed.24392714.s7.e1" text="quetiapine" /><entity charOffset="144-157" id="DDI-PubMed.24392714.s7.e2" text="valproic acid" /><pair ddi="false" e1="DDI-PubMed.24392714.s7.e0" e2="DDI-PubMed.24392714.s7.e0" /><pair ddi="false" e1="DDI-PubMed.24392714.s7.e0" e2="DDI-PubMed.24392714.s7.e1" /><pair ddi="false" e1="DDI-PubMed.24392714.s7.e0" e2="DDI-PubMed.24392714.s7.e2" /><pair ddi="false" e1="DDI-PubMed.24392714.s7.e1" e2="DDI-PubMed.24392714.s7.e1" /><pair ddi="false" e1="DDI-PubMed.24392714.s7.e1" e2="DDI-PubMed.24392714.s7.e2" /></sentence><sentence text="" /><sentence text="Evidence of a possible clinically relevant DDI between valproic acid and both antipsychotics has been uncovered"><entity charOffset="55-68" id="DDI-PubMed.24392714.s9.e0" text="valproic acid" /></sentence><sentence text=" A possible mechanism for the interactions has been postulated, and the importance of TDM has been discussed" /><sentence text="" /><sentence text="Further research is required to determine whether DDIs occur with the concurrent use of valproic acid and olanzapine or quetiapine, and to investigate the potential of TDM as a clinical tool in improving pharmacotherapy and preventing toxicity"><entity charOffset="88-101" id="DDI-PubMed.24392714.s12.e0" text="valproic acid" /><entity charOffset="106-116" id="DDI-PubMed.24392714.s12.e1" text="olanzapine" /><entity charOffset="120-130" id="DDI-PubMed.24392714.s12.e2" text="quetiapine" /><pair ddi="false" e1="DDI-PubMed.24392714.s12.e0" e2="DDI-PubMed.24392714.s12.e0" /><pair ddi="false" e1="DDI-PubMed.24392714.s12.e0" e2="DDI-PubMed.24392714.s12.e1" /><pair ddi="false" e1="DDI-PubMed.24392714.s12.e0" e2="DDI-PubMed.24392714.s12.e2" /><pair ddi="false" e1="DDI-PubMed.24392714.s12.e1" e2="DDI-PubMed.24392714.s12.e1" /><pair ddi="false" e1="DDI-PubMed.24392714.s12.e1" e2="DDI-PubMed.24392714.s12.e2" /></sentence><sentence text="" /></document>